Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Morgan Stanley analyst Hamza Fodderwala maintains NICE (NASDAQ:NICE) with a Overweight and lowers the price target from $290...
Northland Capital Markets analyst Michael Latimore maintains NICE (NASDAQ:NICE) with a Outperform and maintains $305 price t...
Citigroup analyst Tyler Radke maintains NICE (NASDAQ:NICE) with a Buy and raises the price target from $339 to $346.
JMP Securities analyst Patrick Walravens reiterates NICE (NASDAQ:NICE) with a Market Outperform and maintains $300 price tar...
Wedbush analyst Daniel Ives reiterates NICE (NASDAQ:NICE) with a Outperform and maintains $250 price target.
DA Davidson analyst Gil Luria maintains NICE (NASDAQ:NICE) with a Buy and maintains $300 price target.
RBC Capital analyst Rishi Jaluria maintains NICE (NASDAQ:NICE) with a Outperform and lowers the price target from $265 to $230.
